CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Calcitonin gene-related peptide (CGRP) is a neuropeptide with diverse physiological
functions. Its two isoforms (α and β) are widely expressed throughout the body in sensory …
functions. Its two isoforms (α and β) are widely expressed throughout the body in sensory …
Endothelial dysfunction and vascular disease–a 30th anniversary update
PM Vanhoutte, H Shimokawa, M Feletou… - Acta …, 2017 - Wiley Online Library
The endothelium can evoke relaxations of the underlying vascular smooth muscle, by
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …
Calcitonin gene-related peptide: physiology and pathophysiology
FA Russell, R King, SJ Smillie, X Kodji… - Physiological …, 2014 - journals.physiology.org
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide. Discovered 30
years ago, it is produced as a consequence of alternative RNA processing of the calcitonin …
years ago, it is produced as a consequence of alternative RNA processing of the calcitonin …
The metabolic face of migraine—from pathophysiology to treatment
Migraine can be regarded as a conserved, adaptive response that occurs in genetically
predisposed individuals with a mismatch between the brain's energy reserve and workload …
predisposed individuals with a mismatch between the brain's energy reserve and workload …
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
T de Vries, CM Villalón… - Pharmacology & …, 2020 - Elsevier
Migraine is a highly disabling neurovascular disorder characterized by a severe headache
(associated with nausea, photophobia and/or phonophobia), and trigeminovascular system …
(associated with nausea, photophobia and/or phonophobia), and trigeminovascular system …
Calcitonin gene-related peptide (CGRP): a new target for migraine
AF Russo - Annual review of pharmacology and toxicology, 2015 - annualreviews.org
Migraine is a neurological disorder that manifests as a debilitating headache associated
with altered sensory perception. The neuropeptide calcitonin gene-related peptide (CGRP) …
with altered sensory perception. The neuropeptide calcitonin gene-related peptide (CGRP) …
The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects
Z Kee, X Kodji, SD Brain - Frontiers in physiology, 2018 - frontiersin.org
Calcitonin gene-related peptide (CGRP) is a highly potent vasoactive peptide released from
sensory nerves, which is now proposed to have protective effects in several cardiovascular …
sensory nerves, which is now proposed to have protective effects in several cardiovascular …
Gepants for the treatment of migraine
A Negro, P Martelletti - Expert opinion on investigational drugs, 2019 - Taylor & Francis
Introduction: Migraine is the most common of all neurological disorders. A breakthrough in
migraine treatment emerged in the early nineties with the introduction of 5-HT1B/D receptor …
migraine treatment emerged in the early nineties with the introduction of 5-HT1B/D receptor …
Blood pressure in patients with migraine treated with monoclonal anti-CGRP (receptor) antibodies: a prospective follow-up study
S de Vries Lentsch, BWH van der Arend… - Neurology, 2022 - AAN Enterprises
Background and Objectives Anti–calcitonin gene-related peptide (CGRP)(receptor)
antibodies are approved as preventive treatment for migraine. Recent concerns have been …
antibodies are approved as preventive treatment for migraine. Recent concerns have been …
Wiping out CGRP: potential cardiovascular risks
A MaassenVanDenBrink, J Meijer, CM Villalón… - Trends in …, 2016 - cell.com
Migraine is a common episodic neurovascular brain disorder associated with increased risk
of cardio-and cerebrovascular ischemia. Migraine headache is likely caused by activation of …
of cardio-and cerebrovascular ischemia. Migraine headache is likely caused by activation of …